GREENLIGHT CAPITAL INC

Q3 2017 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Daniel Roitman - Chief Operating Officer
Location
New York, NY
Holdings as of
30 Sep 2017
Value $
$412,955,000
Num holdings
1
Filing time
21 Nov 2017, 10:00:29 UTC
Form type
13F-HR/A-1 - New Holdings
Description
Top holdings included BHF. Request for Confidential Treatment (14 Nov 2017): Confidential Treatment Expired on 21 Nov 2017.
Previous filing
Q2 2017 - 14 Aug 2017
Next filing
Q4 2017 - 14 Feb 2018
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Nov 2017 pursuant to a request for confidential treatment and for which confidential treatment expired on 21 Nov 2017.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Daniel Roitman Chief Operating Officer New York, New York 21 Nov 2017

Other Included Managers (2):

Num Name Location File Number
1 DME Advisors, LP New York, NY 028-13228
2 DME Capital Management, LP New York, NY 028-14000